Atrium Therapeutics, Inc. (RNA) free cash flow

Free cash flow · fiscal 2025
-$42.57M

Atrium Therapeutics, Inc. (RNA) generated free cash flow of -$42.57M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$22.82M. Figures as of 18 Nov 2026, 11:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$42.57M
Highest on record
$56.07Mfiscal 2023
Lowest on record
-$139.09Mfiscal 2022
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Atrium Therapeutics, Inc. free cash flow, in more detail

Across the 8 fiscal years on record (2018–2025), the highest was $56.07M in fiscal 2023 and the lowest -$139.09M in fiscal 2022.

History · 8 fiscal years

Free cash flow by fiscal year

Atrium Therapeutics, Inc. free cash flow, year by year

Atrium Therapeutics, Inc. (RNA) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$42.57M—
2024-$22.82M 140.7% down
2023$56.07M—
2022-$139.09M—
2021-$98.55M—
2020-$38.21M 1,794.4% down
2019$2.26M—
2018-$9.70M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on RNA

Atrium Therapeutics, Inc., figure by figure

Atrium Therapeutics, Inc. (RNA) overview: price, valuation and scorecard

Atrium Therapeutics, Inc. free cash flow: questions and answers

What is Atrium Therapeutics, Inc.'s free cash flow?

Atrium Therapeutics, Inc. (RNA) generated free cash flow of -$42.57M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$22.82M.

What are the highest and lowest free cash flow figures on record for Atrium Therapeutics, Inc.?

Across the 8 fiscal years on record (2018–2025), the highest was $56.07M in fiscal 2023 and the lowest -$139.09M in fiscal 2022.

How is Atrium Therapeutics, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Atrium Therapeutics, Inc. it is on record here for 8 fiscal years, 2018 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Atrium Therapeutics, Inc. (RNA) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/RNA/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.